| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/02/1991 | EP0425212A2 Cyclic anti-aggregatory peptides |
| 05/02/1991 | EP0425211A1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles |
| 05/02/1991 | EP0425096A1 Polypeptides useful as blockers of calcium channels |
| 05/02/1991 | EP0424929A1 Isoquinolone derivatives, their production and use |
| 05/02/1991 | EP0424901A1 Dihydropyridine derivatives and pharmaceutical compositions |
| 05/02/1991 | EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas |
| 05/02/1991 | EP0424543A1 New s-adenosylmethionine derivative |
| 05/02/1991 | EP0424386A1 Device for site directed neovascularization and method for same |
| 05/01/1991 | CN1051042A Process for preparing derivatives substituted in position 15 of 20,21 dinoreburnamenine |
| 05/01/1991 | CN1051039A W-phenoxy-heterocyclic compounds |
| 05/01/1991 | CN1051038A Benzoheterocyclic compounds |
| 05/01/1991 | CA2028986A1 Application of n-methy (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2 oxyd-1 to the preparation of medications for treatment of coronary failure |
| 05/01/1991 | CA2028985A1 Process for the preparation of (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r), (pyridyl-3)-2 tetrahydrothiopyranecarbothioamide-2-oxydes-1-(1r,2r) thus obtained and pharmaceutical compositions containing the |
| 05/01/1991 | CA2028880A1 Condensed imidazole derivatives and processes for preparation thereof |
| 05/01/1991 | CA2028798A1 Benzylpyrrolidine derivatives as dopamine agonists |
| 05/01/1991 | CA2028764A1 1-(4-aminophenyl)-2-piperidinopropanone derivatives, preparation process and use in therapeutics |
| 05/01/1991 | CA2028668A1 Compounds |
| 05/01/1991 | CA2028621A1 Antithrombotic substituted cycloalkano[b]dihydroindole- and -indole-sulphonamides |
| 05/01/1991 | CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor |
| 05/01/1991 | CA2025189A1 Method for using (2-imidazolin-2-ylamino)quinoxalines to reduce or maintain intraocular pressure |
| 04/30/1991 | US5011952 Phospholipase A2 inhibitor |
| 04/30/1991 | US5011931 Process for the preparation of 1-methyl-3-methylthio-4-quinolone and the sulfinyl, and sulfonyl analogs thereof |
| 04/30/1991 | US5011930 Antilipemic agents, anticoagulants |
| 04/30/1991 | US5011859 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
| 04/30/1991 | US5011856 Side effect reduction |
| 04/30/1991 | US5011848 Cardiovascular disorders, hypotensive agents |
| 04/30/1991 | US5011847 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
| 04/30/1991 | US5011839 3(2H)pyridazinones for antagonistic agent against srs-a |
| 04/30/1991 | CA1283657C 1,5-benzothiazepine derivatives, their preparation and compositions containing them |
| 04/28/1991 | WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/28/1991 | CA2028645A1 Use of arylalkylamides in the treatment of neurodegenerative diseases |
| 04/28/1991 | CA2028538A1 4-substituted isoquinolone derivatives, their production and use |
| 04/27/1991 | CA2028394A1 Dihydropyridine derivatives and pharmaceutical compositions |
| 04/26/1991 | WO1991006542A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 04/26/1991 | CA2065305A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 04/26/1991 | CA2028610A1 Triazolo derivatives and process for their preparation |
| 04/26/1991 | CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas |
| 04/26/1991 | CA2027937A1 Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles |
| 04/24/1991 | EP0424317A2 Pyrimidines |
| 04/24/1991 | EP0424248A2 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them |
| 04/24/1991 | EP0424214A1 5-[2-[[2-Amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5H)-benzothiazepine-4-one derivatives, their preparation and their use in therapy |
| 04/24/1991 | EP0424195A1 Imidazoles |
| 04/24/1991 | EP0424194A2 Benzanilide derivatives and their use as anti-atherosclerotic agents |
| 04/24/1991 | EP0423805A2 Condensed purine derivatives |
| 04/24/1991 | EP0423802A1 Phenoxy-heterocyclic compounds |
| 04/24/1991 | EP0423366A1 Phospholipid derivatives |
| 04/24/1991 | CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
| 04/24/1991 | CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
| 04/23/1991 | US5010185 Processes for tigogenin beta-cellobioside |
| 04/23/1991 | US5010096 Administering benzodioxino pyrrole compounds; adrenergic blocking agents |
| 04/23/1991 | US5010095 N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine |
| 04/23/1991 | US5010093 Nitric ester derivative |
| 04/23/1991 | US5010088 Inotropic agents |
| 04/23/1991 | US5010072 Lactamimides as calcium antagonists |
| 04/23/1991 | US5010064 Anticoagulants |
| 04/23/1991 | US5010059 Pharmaceutical products and lactosyl compounds |
| 04/23/1991 | US5010057 Renin-inhibiting peptides having an aminomethyl side chain |
| 04/23/1991 | CA1283499C Peptides |
| 04/23/1991 | CA1283418C Cardiotonic alkanoylthiazolones |
| 04/22/1991 | CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 04/20/1991 | CA2027839A1 Pyrimidines |
| 04/19/1991 | WO1991005551A1 Antihypertensive compositions and use thereof |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 04/18/1991 | CA2027738A1 5-{2-[(2-amino-2-oxoethyl) (methyl)amino]ethyl}-2,3-dihydro-3-hydroxy-2-(4-methoxyphen yl)-1,5(5h)-benzothiazepin-4-one derivatives, their preparation and their application in therapy |
| 04/18/1991 | CA2027724A1 15-substituted 20,21-dinoreburnamenine derivatives, process for preparing the same and new intermediates thus produced, use thereof as drugs and compositions containing them |
| 04/18/1991 | CA2027702A1 Pyridone products, preparation process, new intermediates obtained, application as drugs and pharmaceutical compositions containing them |
| 04/17/1991 | EP0422895A1 Chemical compounds |
| 04/17/1991 | EP0422889A2 Phenethanolamine compounds |
| 04/17/1991 | EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 04/17/1991 | EP0422666A2 6-Substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/17/1991 | EP0422450A2 Chroman derivatives |
| 04/17/1991 | EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
| 04/17/1991 | EP0422217A1 Human recombinant placental ribonuclease inhibitor and method of production |
| 04/17/1991 | EP0422102A1 5-OXA, 5-THIA, 5-AZA HMG-CoA REDUCTASE INHIBITORS |
| 04/17/1991 | CN1050715A Quinoline derivatives, their production and use |
| 04/16/1991 | US5008400 Bicyclic aminoacids as intermediates |
| 04/16/1991 | US5008399 Diastereoselective preparation of phosphinate esters |
| 04/16/1991 | US5008290 Sulphonamidoethyl compounds and pharmaceutical compositions comprising these compounds |
| 04/16/1991 | US5008279 Inotropic, antihypertensive agents |
| 04/16/1991 | US5008273 Amino acid derivatives and their pharmaceutical use |
| 04/16/1991 | CA1283106C 3-amino-dihydropyridines, a process for their preparation, and their use in medicaments |
| 04/16/1991 | CA1283105C 1,4-dihydropyridines, processes for their preparation and their use in medicaments |
| 04/14/1991 | WO1991005796A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2069312A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2027325A1 6-substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/14/1991 | CA2027169A1 Chemical compounds |
| 04/13/1991 | CA2000650A1 Product and process for the treatment and prevention of intravascular thrombi and atherosclerosis |
| 04/12/1991 | CA2027125A1 Renin inhibitors |
| 04/11/1991 | CA2027262A1 Phenethanolamine derivatives |
| 04/11/1991 | CA2027179A1 Chemical compounds |
| 04/11/1991 | CA2025661A1 Method of improving post-ischemic myocardial function using a thromboxane a antagonist in combination with a thrombolytic agent and combination |
| 04/10/1991 | EP0421861A1 2-Hydroxy thiophene- and furan derivatives condensed with a nitrogen containing ring, process for their preparation and their therapeutical application |
| 04/10/1991 | EP0421456A2 Quinoline derivatives, their production and use |
| 04/10/1991 | EP0421436A2 Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity |
| 04/10/1991 | EP0421284A1 Human endothelin-3 cDNA and use thereof |
| 04/10/1991 | CN1050539A Biphenylmethane derivative and pharmacological use |